WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 11

Volume: 32 Issue: 11

1. Antiviral therapy for chronic hepatitis B: current status and perspectives Page:2029—2032
2. Diagnosis and treatment of hepatitis B virus infection complicated by metabolic syndrome Page:2039—2042
3. Advances in research and development of new drugs for antiviral therapy for chronic hepatitis B Page:2043—2049
4. How to evaluate combination therapy using interferon and nucleos(t)ide analogues Page:2050—2053
5. New considerations in antiviral therapy for special populations with chronic hepatitis B Page:2054—2057
6. Role of liver fibrosis assessment in decision-making and efficacy surveillance for antiviral therapy in patients with chronic hepatitis B Page:2058—2061
7. Research advances in primary biliary cholangitis Page:2062—2065
8. An analysis of medication rule for HBeAg-positive chronic hepatitis B based on association rule and complex system entropy clustering Page:2075—2079
9. Clinical effect of entecavir combined with antituberculosis therapy in patients with tuberculosis complicated by chronic HBV infection Page:2088—2091
10. Clinical features of patients with acute exacerbation of chronic hepatitis B: an analysis of 74 cases Page:2096—2098
11. Correlation between HBsAg, prothrombin time activity, and indocyanine green retention rate at 15 minutes in patients with HBeAg-positive chronic HBV infection Page:2099—2102
12. Value of serum cancer antigen12-5 level in diagnosis of peritoneal effusion in patients with liver cirrhosis Page:2118—2120
13. Role of reproductive factors in female patients with primary biliary cholangitis Page:2130—2133
14. Diagnosis of clonorchiasis during and after biliary tract surgery: a clinical analysis of 15 cases Page:2134—2137
15. Value of cold laser combined with choledochoscopy in treatment of residual stones after biliary surgery Page:2138—2140
16. Application of fast track surgery strategy in perioperative period of primary suture of laparoscopic choledocholithotomy Page:2141—2145
17. Guiding significance of Guideline for diagnosis and treatment of herb-induced liver injury in clinical diagnosis: a retrospective analysis Page:2159—2162
18. Clinical effect of matrine in treatment of rats with nonalcoholic steatohepatitis Page:2163—2166
19. Research advances in tenofovir in treatment of chronic hepatitis B patients with drug resistance Page:2182—2185
20. Influence of interaction between endogenous miRNAs and hepatitis B virus in hepatocytes on hepatitis B virus transcription and related mechanisms Page:2186—2190
21. Mechanisms of hyponatremia in patients with decompensated liver cirrhosis treated with terlipressin and related treatment principles Page:2191—2194
22. Regulatory effect of transforming growth factor-β on activation of hepatic stellate cells Page:2195—2198
23. Prevention of surgical site infection after liver cancer resection Page:2199—2202
24. Diagnostic value of H19 gene in hepatocellular carcinoma Page:2203—2205
25. Expression and role of heat shock protein 70 in hepatocellular carcinoma Page:2206—2209
26. Value of ultrasonic elastography in diagnosis of liver diseases Page:2210—2213
27. Research advances in diagnosis and treatment of liver disease during pregnancy Page:2214—2217
28. Research advances in pathogenesis and management of fatigue in patients with primary biliary cirrhosis Page:2218—2221
29. Role of chymotrypsin C in development and progression of pancreatitis and pancreatic cancer Page:2222—2225

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.